Clinical Trial Update: Hemodynamic-GUIDEd Management of Heart Failure [NA]

View source ↗

Summary

Abbott Medical Devices completed a trial on hemodynamic-guided management of heart failure; results were posted on 2025-08-07.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Heart Failure with Preserved Ejection Fraction
• Heart Failure with Reduced Ejection Fraction

Drugs mentioned

• CardioMEMS HF System

Snippet

Sponsor: Abbott Medical Devices | Conditions: Heart Failure, Heart Failure, Systolic | NA | Status: COMPLETED | Results posted: 2025-08-07